Similarly, in prostate cancer the expression of the miRNA cluster was downregulated, which was associated with upregulation of target genes BCL2, CCND1 and WNT3A. Knockdown of miR-15a and miR-16 in an in vitro model enhanced cancer progression by affecting cell survival, proliferation and invasion [38]. The gene discussed is BCL2; the disease is prostate carcinoma.